Strategic leadership MedWand has recently elevated leadership with Todd Cornell as CEO and Mike Welch as Global VP of Sales and Marketing, signaling a strengthened go-to-market strategy and commitment to scaling sales efforts in telemedicine hardware and remote diagnostics.

Expanding capabilities The FDA-approved all-in-one device plus third-party peripheral integrations creates cross-sell opportunities with clinics and hospitals seeking bundled telemedicine solutions for vitals, imaging, and remote monitoring.

Regulatory roadmap Electrocardiogram functionality awaiting FDA clearance presents a near-term upgrade path and sales angle to customers prioritizing comprehensive remote cardiac assessment once clearance is obtained.

SMB to mid-market With a small-to-mid-sized company footprint and revenue in the low-to-mid single digits, MedWand is positioned to win adopters in clinics and urgent care networks looking for scalable, user-friendly telemedicine devices.

Global expansion signals Recent executive hires and international appeal of the multi-sensor device indicate opportunities to target international markets and multi-site health systems seeking telehealth hardware with high-definition imaging and integrated vitals.